Decreased CD28 expression has been observed in some types of cancer, for example, in the dysfunctional peripheral T-lymphocytes from patients with hairy cell leukemia [21] and chronic lymphocytic leukemia [22], as well as in colorectal cancer patients [23]. This evidence concerns the gene CD28 and cancer.